Filing Details
- Accession Number:
- 0001209191-20-047402
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-18 21:47:10
- Reporting Period:
- 2020-08-14
- Accepted Time:
- 2020-08-18 21:47:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1527753 | Personalis Inc. | PSNL | Services-Medical Laboratories (8071) | 275411038 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1779787 | Richard Chen | C/O Personalis, Inc. 1330 O'Brien Drive Menlo Park CA 94025 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-14 | 28,566 | $0.00 | 148,709 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-14 | 3,434 | $19.76 | 145,275 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-14 | 27,366 | $20.17 | 117,909 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-14 | 1,200 | $20.47 | 116,709 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-14 | 27,913 | $0.00 | 27,913 | $0.44 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-14 | 653 | $0.00 | 653 | $1.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 109,336 | 2022-03-07 | No | 4 | M | Direct | |
| 54,346 | 2023-11-13 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person.
- The weighted average sales price for the transaction reported was $19.76, and the range of prices was between $19.36 and $20.18 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $20.17, and the range of prices was between $19.45 to $20.44 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $20.47, and the range of prices was between $20.45 to $20.48 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
